Search This Blog

Wednesday, January 2, 2019

JPMorgan adds Novo Nordisk to Analyst Focus List, removes Roche


JPMorgan analyst Richard Vosser added Novo Nordisk (NVO) to his firm’s European Analyst Focus List while removing Roche (RHHBY).
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)